CONTRACTURAL OBLIGATIONS AND CONTINGENCIES (Details Narrative) (USD $)	1 Months Ended	9 Months Ended		12 Months Ended
	Jan. 31, 2011	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 1995	Dec. 31, 1994
Loss Contingencies [Line Items]
Contingent remaining obligations to repay		$ 969	$ 1,306	$ 198,365	$ 165,701
Obligation expenses		87	0
Percentage of revenues obligation		0.075%
Lease term	2 years
Averaged obligations under lease	27,000
Payment of landlord fees		15,000
Unpaid of landlord fees		9,000
Carolina Liquid | Case pending
Loss Contingencies [Line Items]
Lawsuit filing date		29-Aug-05
Name of defendant		Carolina Liquid Chemistries Corporation (""Carolina Liquid"") and Catch, Inc. (""Catch"") and the Diazyme Laboratories Division of General Atomics (""Diazyme"")
Domicile of litigation		United States District Court for the District of Colorado
Description of allegations		Alleging patent infringement of our patent covering homocysteine assays, and seeking monetary damages, punitive damages, attorneys? fees, court costs and other remuneration at the option of the court.
Description about actions taken by defendant		Diazyme filed for declaratory judgment in the Southern District of California for a change in venue and a declaration of non-infringement and invalidity.
Description of request for information		Diazyme requested the United States Patent and Trademark Office (the ""USPTO"") to re-evaluate the validity of our Patent and this request was granted by the USPTO on December 14, 2006.
Employment matters (Whistleblower Complaint) | Case pending
Loss Contingencies [Line Items]
Lawsuit filing date		In September 2003
Domicile of litigation		U. S. Occupational Safety and Health Administration (?OSHA?)
Description of allegations		Alleging that the employee had been terminated for engaging in conduct protected under the Sarbanes Oxley Act of 2002 (?SarbOx?).
John B. Nano vs. Competitive Technologies, Inc
Loss Contingencies [Line Items]
Lawsuit filing date		13-Sep-10
Domicile of litigation		American Arbitration Association
Description of allegations		Board of Directors of CTI found cause consisting of violation of fiduciary duties to the Company and violation of the CTI Corporate Code of Conduct and removed John B. Nano as an officer of the Company in all capacities. On September 13, 2010, the Board of Directors also found cause consisting of violation of fiduciary duties to the Company and violation of the CTI Corporate Code of Conduct; and subsequently, removing John B. Nano (?Nano?) as a director of CTI?s board and in all capacities, for cause, consisting of violation of his fiduciary duties.
Estimate of possible loss		750,000
Additional damages paid to plaintiff as statutory interest		25,000
Total damages paid to plaintiff		$ 775,000